Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy

Affiliations

• ¹ Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, Gainesville, Florida, USA.
• ² Center for Pharmacogenomics and Precision Medicine, University of Florida, Gainesville, Florida, USA.
• ³ Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.
• ⁴ Department of Biomedical Data Science, Stanford University, Stanford, California, USA.
• ⁵ Institute of Molecular Pathology Biomarkers, University of Extremadura, Cáceres, Spain.
• ⁶ Department of Pharmacy Practice, South Dakota State University College of Pharmacy & Allied Health Professions, Brookings, South Dakota, USA.
• ⁷ Sanford Imagenetics, Sioux Falls, South Dakota, USA.
• ⁸ Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Research Institute and School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA.
• ⁹ Center for Individualized and Genomic Medicine Research (CIGMA), Henry Ford Hospital, Detroit, Michigan, USA.
• ¹⁰ Heart and Vascular Institute, Henry Ford Health, Detroit, Michigan, USA.
• ¹¹ Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
• ¹² Department of Pharmaceutical Services, Children's Cancer Hospital Egypt 57357, Cairo, Egypt.
• ¹³ Personalized Medication Management Unit, Children's Cancer Hospital Egypt 57357, Cairo, Egypt.
• ¹⁴ Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
• ¹⁵ Department of Clinical Pharmacology, University Hospital Tuebingen, Tuebingen, Germany.
• ¹⁶ Department of Biochemistry and Pharmacy, University Tuebingen, Tuebingen, Germany.
• ¹⁷ Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
• ¹⁸ Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
• ¹⁹ Division of Pediatric Oncology and Hematology, Department of Women, Child and Adolescent, University Geneva Hospitals, Geneva, Switzerland.
• ²⁰ Department of Pediatrics, Gynecology and Obstetrics, Cansearch Research Platform for Pediatric Oncology and Hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
• ²¹ Department of Clinical Chemistry, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
• ²² Department of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts, USA.
• ²³ Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
• ²⁴ Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA.